Table 3.
Ocular health at baseline according to treatment arm (n = 84 neonates, 111 affected eyes).
| Euphrasia (n = 52 eyes) | Missing data | Placebo (n = 59 eyes) | Missing data | |
|---|---|---|---|---|
| Symptoms at baseline | ||||
| Ocular discharge | 50 (96.2%)a | - | 59 (100%) | - |
| Type of ocular discharge | 1 | - | ||
| White | 5 (10.2%) | 8 (13.6%) | ||
| Yellow | 40 (81.6%) | 50 (84.7%) | ||
| Green | 4 (8.2%) | 1 (1.7%) | ||
| Reddening | 33 (63.5%) | - | 21 (36.2%) | 1 |
| Tearing | 34 (66.6%) | 1 | 36 (63.2%) | 2 |
Data are expressed as number (percentage).
a
Two neonates were randomized though they did not present with ocular discharge at baseline.